Supervalu pharmacies become first to accept e-Rxs for controlled substances
EDEN PRAIRIE, Minn. — Supervalu has expanded its offering to accept e-prescriptions for controlled substances at its banner pharmacies after meeting stringent regulatory requirements set by the Drug Enforcement Administration.
While Shoppers and Farm Fresh banner pharmacies in Virginia, along with Albertsons Sav-On pharmacies in Southern California, are the first pharmacies within the chain to accept e-prescriptions for controlled substances — drugs or other substances that are regulated under federal law depending on medical use, potential for abuse and addictiveness — in the coming weeks, the offering will expand to such banner pharmacies as Acme Sav-On, Cub, Jewel-Osco, Shaw’s, Shop ‘n Save and Shop ‘n Save Osco, where approved by state law.
All pharmacies must undergo a credentialing process to accept e-prescriptions for controlled substances, Supervalu said. These security and regulatory requirements are administered by the DEA and must be adhered to.
“Supervalu pharmacies are pleased to provide this added level of service and convenience of e-prescriptions for our patients who require prescriptions of controlled substances,” Supervalu pharmacies president Chris Dimos said. “This capability is another way our pharmacists combine technology and personal service to decrease our customers’ wait times for prescriptions.
“E-prescriptions are especially convenient for patients with multiple prescriptions for controlled and noncontrolled substances,” Dimos said. “Now all these prescriptions can be electronically issued at one time and promptly filled, requiring no additional paperwork or waiting.”
Fred Meyer preps for flu season with needle-free vaccine option
PORTLAND, Ore. — Fred Meyer customers seeking to be immunized against the flu this fall now have a needle-free option.
The retailer announced Thursday that stores across Alaska, Idaho, Oregon and Washington offer both traditional flu shots and a needle-free option, which is manufactured by Bioject Medical Technologies.
“While needle-free vaccines have been used in the past in some public agencies and the military, this is the first time this option has been available to the public through their pharmacies,” Fred Meyer VP and director of pharmacy Marc Cecchini said. “This provides a great alternative for customers who are wary of needles but want to protect themselves against the flu.”
JDRF, InnoCentive launch challenge for treatment of diabetes
WALTHAM, Mass. — The Juvenile Diabetes Research Foundation and InnoCentive are calling for innovative ways to approach the discovery and development of a glucose-responsive insulin drug as a means to treat Type 1 diabetes.
JDRF and InnoCentive’s $100,000 Challenge is open to anyone with a solution that fits the published criteria and requires a written proposal. Submissions will be accepted through Nov. 9. The winning solution from this challenge could be further developed into a second phase, named the preclinical proof of principle “validation phase,” JDRF and InnoCentive said. This second phase would require a detailed research plan proposal and could offer the winning solver(s) the opportunity to become a member(s) of the team created to put the winning solution into practice.
“JDRF is an organization that recognizes the importance of innovation in the healthcare industry,” InnoCentive president and CEO Dwayne Spradlin said. “This approach of looking beyond traditional researchers to gain new insights, ideas and solutions illustrates their commitment to finding a better way to treat diabetes. We are excited to be partnering with JDRF to find new ways to enhance the quality of life for patients while helping patients better manage their disease.”